Literature DB >> 17029247

Validity and consequence of informed consent in pediatric bone marrow transplantation: The parental experience.

Jan M Benedict1, Christy Simpson, Conrad V Fernandez.   

Abstract

BACKGROUND: Conditions supporting a high quality of consent for pediatric bone marrow transplantation (BMT) are suboptimal given the complexity of the procedure, lack of options, and parent emotional duress. We studied if parents perceived choice when consenting to BMT, if they felt the consent provided was valid, and how the consent process affected them.
METHODS: Telephone or face-to-face interviews were recorded using a semi-structured interview outline. Interview transcripts were anonymized, and independently analyzed by three reviewers.
RESULTS: Twenty parents of twelve children participated, including five bereaved parents. There were no differences in patient transplant characteristics between the eligible and study groups. Divorced or separated parents were underrepresented in the participant group. Fifteen parents felt personally compelled to consent; most (18) denied feeling external medical pressure to do so. All parents felt their consent was valid and most reported adequate levels of freedom, capacity, and information. Expectations formulated during the consent process strongly influenced parents' experience post-BMT. Good communication during consent contributed to trust and therapeutic alliance with physicians following BMT. Late parental stress and anxiety were periodic, but very high in some families.
CONCLUSIONS: Parents feel consent for pediatric BMT is valid, despite feeling personally compelled to consent. Strategies aimed at nurturing hope and realistic expectations may assist in improving the consent process, while diminishing long-term stressors. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17029247     DOI: 10.1002/pbc.21073

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  7 in total

1.  Shared decision-making in pediatric allogeneic blood and marrow transplantation: what if there is no decision to make?

Authors:  Rebecca D Pentz; Wendy Pelletier; Melissa A Alderfer; Kristin Stegenga; Diane L Fairclough; Pamela S Hinds
Journal:  Oncologist       Date:  2012-05-21

2.  Factors related to voluntary parental decision-making in pediatric oncology.

Authors:  Victoria A Miller; Robert M Nelson
Journal:  Pediatrics       Date:  2012-04-16       Impact factor: 7.124

3.  Relationship of external influence to parental distress in decision making regarding children with a life-threatening illness.

Authors:  Victoria A Miller; Mary Frances Luce; Robert M Nelson
Journal:  J Pediatr Psychol       Date:  2011-06-21

4.  Variation in supportive care practices in hematopoietic cell transplantation.

Authors:  Stephanie J Lee; Claudia C Astigarraga; Mary Eapen; Andrew S Artz; Stella M Davies; Richard Champlin; Madan Jagasia; Nancy A Kernan; Fausto R Loberiza; Margaret Bevans; Robert J Soiffer; Steven Joffe
Journal:  Biol Blood Marrow Transplant       Date:  2008-11       Impact factor: 5.742

5.  Parent Outlook: How Parents View the Road Ahead as They Embark on Hematopoietic Stem Cell Transplantation for Their Child.

Authors:  Christina K Ullrich; Angie Mae Rodday; Kristin Bingen; Mary Jo Kupst; Sunita K Patel; Karen L Syrjala; Lynnette L Harris; Christopher J Recklitis; Lisa Schwartz; Stella Davies; Eva C Guinan; Grace Chang; Joanne Wolfe; Susan K Parsons
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-05       Impact factor: 5.742

Review 6.  Parental permission and child assent in research on children.

Authors:  Michelle Roth-Cline; Robert M Nelson
Journal:  Yale J Biol Med       Date:  2013-09-20

7.  Expectations and experience: Parent and patient perspectives regarding treatment for Severe Combined Immunodeficiency (SCID).

Authors:  Heather Smith; Christopher Scalchunes; Morton J Cowan; Jennifer Puck; Jennifer Heimall
Journal:  Clin Immunol       Date:  2021-06-16       Impact factor: 10.190

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.